5th Symposium

24/25 May 2012

Practical focus on the diagnosis and treatment of the psychiatric and neuropsychological aspects of HIV-infected patients.

Milton Wainberg, M.D.

Columbia University. New York, USA

Diagnosis and Management of Anxiety Disorders

Paola Cinque, M.D.

Hospital San Rafael. Milan, Italy

Screening for Neurocognitive Impairment: A Practical Approach

Dr. Jose Catalan, MSc(Oxon), DPM

Department Psychiatry, South Kensington and Chelsea Mental Health Centre and Chelsea and Westminster Hospital. London, United Kingdom.

 

Spectrum and Management of Sexual Problems in People with HIV Infection

Scott Letendre, M.D.

University of California. San Diego, USA

Antiretroviral Therapy for Prevention and Management of HIV-Associated Neurocognitive Impairment: What is really changing?

Emili Fernández-Egea, M.D., Ph.D.

Behavioural and Clinical Neuroscience Institute and Department of Psychiatry. University of Cambridge. United Kingdom.

Safety and Compliance of Psychopharmacological Therapy

Alan Winston, M.D.

St. Mary’s Hospital. London, United Kingdom

Asymptomatic NCI

José Ramón Arribas, M.D.

Infectious Diseases Unit, Internal Medicine. La Paz University Hospital. AIDS and Infectious Diseases Research Group of IdiPAZ. Madrid, Spain

Protease-Inhibitor Monotherapy: Friend or Foe?

Jose A. Muñoz-Moreno, Ph.D.

Lluita contra la SIDA Foundation. Barcelona, Spain.

Workshop: Neuropsychological Screening HIV Infection: How to Implement this Assessment in the Clinical Practice?

Carmina R. Fumaz, Ph.D.

HIV Day Hospital-Hospital Universitari Germans Trias i Pujol. Barcelona, Spain.

Workshop: Application of the Mindfulness-Based Stress Reduction Program in Subjects Living with HIV Infection